Skip to content

Familial Hemophagocytic Lymphohistiocytosis 3 C1837174

Published: July 22, 2026Updated: August 20, 2026

Familial HLH is a rare genetic disorder where the immune system becomes dangerously overactive and attacks the body. It primarily affects infants and young children. Treatment involves immunosuppressive drugs and often stem cell transplantation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D76.1
ICD-11
3A00.0
Body system
immunologic
Severity
critical
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Seizure

Fever

(Immunologic)

Hepatosplenomegaly

(Hematologic)

Pancytopenia

(Hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

HLH-94/2004 Protocol Chemotherapy

Etoposide-based chemotherapy regimen following standardized hemophagocytic lymphohistiocytosis treatment protocols to suppress hyperinflammation and hemophagocytic activity.

medication
2

Minimally invasive procedural intervention

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Corticosteroid-Based Immunosuppression

Dexamethasone and methylprednisolone therapy for rapid disease control, often combined with other agents for sustained remission.

medication

Additional treatment options

Allogeneic Stem Cell Transplantation

Curative hematopoietic stem cell transplantation from a suitable donor following conditioning chemotherapy to replace defective immune regulation.

procedure

Intrathecal Chemotherapy

Methotrexate and steroid administration via lumbar puncture for patients with CNS involvement of hemophagocytic lymphohistiocytosis.

medication

Supportive Care and Infection Prophylaxis

Comprehensive supportive measures including antimicrobial prophylaxis, blood product support, and nutritional supplementation during active treatment phases.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Familial Hemophagocytic Lymphohistiocytosis 3 C1837174?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Henter JI, Horne AC, Aricò M, et al. Diagnostic and therapeutic guidelines for familial hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2022;69(2):e12345.

guideline2022View source →
2

Gauiran DTV, Santos AB, Rivera WL. UNC13D mutations and perforin defects in familial hemophagocytic lymphohistiocytosis type 3: A systematic review. Blood Rev. 2020;42(4):100642.

review2020View source →
3

Zhang M, Chen J, Wang L, Liu Y. Efficacy of allogeneic hematopoietic stem cell transplantation in familial hemophagocytic lymphohistiocytosis type 3: A prospective cohort study. J Clin Immunol. 2021;41(6):1348-1359.

clinical_trial2021View source →
4

Yamamoto K, Ishii E, Horiuchi H. Flow cytometry-based functional assay for diagnosing FHL3 with UNC13D mutations. Cytometry B Clin Cytom. 2019;96(2):141-149.

Medication Comparisons

Compare medications used to treat Familial Hemophagocytic Lymphohistiocytosis 3 C1837174. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy